Potential Drug Interactions with Coumadin (Warfarin) and Prozac (Fluoxetine): A Brief Report and Review of the Literature by Claire, M.D., Robert Jay et al.
Potential Drug Interaction with Coumadin
(Warfarin) and Prozac (Fluoxetine): A Brief
Report and Review of the Literature
Robert Jay Claire, M.D.
Mark E. Servis, M.D.
David L. Cram, Jr., Pharm. D.
Abstract
We were askedto see a woman with recurrent depression and a history ifdeep vein thrombosis.
(Consultation and L iaison Service). She had been started initially on Prorac (fluoxetine) and was
secondarily started on Coumadin (uiaifarin). The patient presented with severe bruising if both
lower extremities. We were asked to investigate the case to determine if a drug interaction with
Prozac had produced the problem. A review if the world's literaturefai led to produce a report ifa
drug interaction between Prozac and Coumadin producing a bleeding disorder. Scrutiny ifthis case
could not produce evidence that this occurred. A retrospective analysis if 4 additional cases was
performed. None ifthesepatients requiredadjustment iftheir Coumadin while on Prozac.
It would be reasonable to assume that as th e mean age of th e U nited States
population rises , th e inciden ce of como rbid medi cal a nd psychi a tric d isease is
incr easing. Patients a re oft en pr escribed medi cations whi ch may int eract with
psychotropic drugs . Second-generation ant idepressants a re ge ne ra lly cons idered safe
drugs in th e medi call y ill popu lation because of their minimal a n t icho linerg ic
properties and fewer adverse sid e effec ts. Fo r th e ph ysician , a kn owled ge of drug
interactions with th e most com monly prescribed psychotropic medi cations is not only
helpful , but should be th e standard of ca re.
Recen tly, we were asked to see a woman with recurrent depression a nd a history
of deep vein thrombosis . Sh e had been initially s tar te d on Prozac (fluoxe t ine ) an d
was secondarily started on Co umad in (warfarin) . The pat ient pr esent ed with seve re
bru ising of both lower ex t re mi t ies and a seco ndary cellu litis . An added com plica ting
fact was that she had a Di ptheria , Pertussis, T et anus vaccination 3 weeks prior to
ad mission. Bot h ce llulitis and th e D.P.T. vaccin at ion pot entially int e rfere with
coag ula t ion. On admission her Proth rom bin Tim e (PT) was 50 a nd Part ial Thromb o-
plastin Time (PTT) was 100, a sce nario more cons iste nt with a coagulopa thy rather
than Coumadin toxicity.
When as ked to consult on this case , we had to investigat e th e possibil ity of
Prozac interact ing wit h Coumadin. The Ph ysicia ns Desk Reference ca u tions agains t
coa d ministe r ing th e two drugs . (I)
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Co umadin, a com mo nly pr escribed a nt icoagula n t , is bound to th e sam e plasma
pr ot ei n which binds Prozac. It is possibl e th at Pr ozac may di splace Coumadin from its
binding protein a nd result in a n incr ease in a fr ee fract ion of Coumadin , ca using an
incr ease in Protim e ( 1,3,) . A se a rc h of th e medi cal lit era ture fai ls to demonst ra te any
cases of Pro zac interacting with C oumadin (2). In our case, a defini te ca use a nd effect
linkage could not be es tablishe d.
It was th en elec te d to perform a ret rosp ecti ve char t revi ew of patients who were
coa d mi niste re d Prozac and Coumad in . T o dat e, we have rev iewed an addition al 4
cases .
Patient A is a 75 year old white male with a hist ory of chronic obstructiv e
pulmon a ry disease, co ro na ry a r tery di sease, multiple myoca rdi a l infarct s, a t r ia l
fibrilla t ion, a nd recurrent t ransient isch e mic a t tacks. The patien t was found to have
major depression and mild dementia. He had been on lon g term Coumadin th er apy
pri or to th e initiation of Prozac. At this juncture, Pr ozac a nd Co umadi n have j ointly
been administered for I yea r. Th e patient mainta ined his PT ra tio between 1.3 a nd
1.5 of PT con t ro l range witho u t need to adj us t th e dosage.
Patient B, a 67 year old mal e, has a history of mu ltiple ce re bra l vasc ular
acc ide n ts. He presented to Mental Hygien e C linic wit h major depression . T o dat e, he
has been maintained on Pr ozac a nd Co umadin for eight week s. Hi s PT has rema ined
within sa t isfac tory cuntrollimits without having to be adjust ed .
Patient C, a 73 year old mal e, is sta tus post coro na ry a rt e ry bypass graft , a nd II
peripheral vascular by-pass gra fts . He has a hist ory of deep vein thrombophlebit is a nd
has been maintained on Cou mad in th erap y for 12 years . He was sta r ted on Prozac for
depression 2 years ago. T o date he ha s required no special ad justment to st ay within
con t rol range.
Patient D is a 67 year old mal e with a history of deep vei n t hrombophleb iti s,
pulmon ary em boli a nd squamo us ce ll ca rcinoma of the tongue. He has undergon e
radi cal neck di ssecti on a nd ex te rnal beam radi ation therapy. The patient has been on
Coumadin for 12 years. Hi s psychi atric hist ory is remarkabl e for schizophreni a and
intermitt ent depression . He was placed on Pr ozac 3 months ago, wh en he experi-
ence d ort hos tat ic blood pressure cha nges from his t ricyclic a ntidepressants. In th e
intervening period , he has required no specia l dosage adjustment to stay within
paramet ers.
Our purpose in writing thi s report is to inform other cli nicians tha t although in
theory Coumadin a nd Prozac may int eract and a lte r Prothrombin Time, th e po ten-
tial a t this time appe a rs small. Both Coumadin an d Pr ozac ca n eas ily be displaced by
other highl y pr ot ein bound drugs. Prozac does not appear to alter the outcom e of
a n ticoag ula n t th erapy significan t ly in th e pa t ie n ts presen te d.
No cases of Coumadin interacting with Prozac have appeared in th e world 's
lit erature (2) . Our investigation involves 5 patients a nd ca nno t be considered
definitive. It would be prudent to study a larger population before th e safet y of it s
com bina tion with Coumadin ca n be det ermined .
Eli Lilly a nd Compan y, th e manufacturers of Pr ozac, re por t that as ofJune 30,
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1990, a pproximate ly 2,382,000 pa tients have been on Prozac. T here have be en only 24
rep ort ed cases of incr ease in bleeding time, coagulation d isord er , or coagula t ion time
increase. We do not kn ow wh eth er a ny of th ese pa t ien ts were concurrently on Pr ozac
and Coumadin . It is our hope th a t this art icle challenges ot her investigator s.
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